These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10751212)

  • 41. Intermedin/adrenomedullin 2 protects against tubular cell hypoxia-reoxygenation injury in vitro by promoting cell proliferation and upregulating cyclin D1 expression.
    Wang Y; Li R; Qiao X; Tian J; Su X; Wu R; Zhang R; Zhou X; Li J; Shao S
    Nephrology (Carlton); 2013 Sep; 18(9):623-32. PubMed ID: 23782291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal damage in obstructive nephropathy is decreased in Skp2-deficient mice.
    Suzuki S; Fukasawa H; Kitagawa K; Uchida C; Hattori T; Isobe T; Oda T; Misaki T; Ohashi N; Nakayama K; Nakayama KI; Hishida A; Yamamoto T; Kitagawa M
    Am J Pathol; 2007 Aug; 171(2):473-83. PubMed ID: 17620370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Links between apoptosis, proliferation and the cell cycle.
    Alenzi FQ
    Br J Biomed Sci; 2004; 61(2):99-102. PubMed ID: 15250676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ASK1/p38 signaling in renal tubular epithelial cells promotes renal fibrosis in the mouse obstructed kidney.
    Ma FY; Tesch GH; Nikolic-Paterson DJ
    Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1263-73. PubMed ID: 25298527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteinuria as a mediator of tubulointerstitial injury.
    Abbate M; Remuzzi G
    Kidney Blood Press Res; 1999; 22(1-2):37-46. PubMed ID: 10352406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of p27KIP1 after unilateral ureteral obstruction is independent of angiotensin II.
    Gerth JH; Kriegsmann J; Trinh TT; Stahl RA; Wendt T; Sommer M; Stein G; Wolf G
    Kidney Int; 2002 Jan; 61(1):68-79. PubMed ID: 11786086
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.
    Al-Douahji M; Brugarolas J; Brown PA; Stehman-Breen CO; Alpers CE; Shankland SJ
    Kidney Int; 1999 Nov; 56(5):1691-9. PubMed ID: 10571777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct Effects of Inorganic Phosphate on Cell Cycle and Apoptosis in Human Vascular Smooth Muscle Cells.
    Rahabi-Layachi H; Ourouda R; Boullier A; Massy ZA; Amant C
    J Cell Physiol; 2015 Feb; 230(2):347-55. PubMed ID: 24976589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential changes of CDK activities in glomeruli and tubules during the active DNA synthetic period after ischemic injury.
    Park SK; Kim W; Lee CH; Koh GY
    Nephron; 2000 Nov; 86(3):306-14. PubMed ID: 11096288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanical stretch induces podocyte hypertrophy in vitro.
    Petermann AT; Pippin J; Durvasula R; Pichler R; Hiromura K; Monkawa T; Couser WG; Shankland SJ
    Kidney Int; 2005 Jan; 67(1):157-66. PubMed ID: 15610239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
    FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell cycle and apoptosis.
    Vermeulen K; Berneman ZN; Van Bockstaele DR
    Cell Prolif; 2003 Jun; 36(3):165-75. PubMed ID: 12814432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vasoactive factors and tubulointerstitial injury.
    Wolf G
    Kidney Blood Press Res; 1999; 22(1-2):62-70. PubMed ID: 10352409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast.
    Wong SC; Chan JK; Lee KC; Hsiao WL
    J Pathol; 2001 May; 194(1):35-42. PubMed ID: 11329139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell cycle control in the kidney.
    Thomasova D; Anders HJ
    Nephrol Dial Transplant; 2015 Oct; 30(10):1622-30. PubMed ID: 25538161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apoptosis in renal diseases.
    Ortiz A; González Cuadrado S; Lorz C; Egido J
    Front Biosci; 1996 Mar; 1():d30-47. PubMed ID: 9159208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apoptosis in the mammalian kidney: incidence, effectors, and molecular control in normal development and disease states.
    Buttyan R; Gobé G
    Adv Pharmacol; 1997; 41():369-81. PubMed ID: 9204152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A theory for controlling cell cycle dynamics using a reversibly binding inhibitor.
    Gardner TS; Dolnik M; Collins JJ
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14190-5. PubMed ID: 9826676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physiology and cell biology update: polypeptide growth factors and their relation to renal disease.
    Kujubu DA; Fine LG
    Am J Kidney Dis; 1989 Jul; 14(1):61-73. PubMed ID: 2662764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role and regulation of apoptotic cell death in the kidney. Y2K update.
    Ortiz A; Lorz C; Catalan MP; Justo P; Egido J
    Front Biosci; 2000 Aug; 5():D735-49. PubMed ID: 10922294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.